Caroline S Russell

This inventor holds 12 USPTO granted patents, plus 1 CIPO patent and 3 EPO patents. Top assignees: Wyeth, Medimmune Limited, Cambridge Antibody Technology Limited. Active years: 2007-2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Caroline S Russell. Retrieved from https://idiyas.com/inventor/caroline-s-russell

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 12

% Patents Active = 33.3

CIPO Patents = 1

EPO Patents = 3 (Patent Applications = 2)

Average Co-Inventor Count = 8.9

ph-index = 7

Forward Citations = 864(Granted Patents)

Location History:

Herts, GB (2007 - 2012)
Hertfordshire, GB (2011 - 2013)
Cambridge, GB (2012 - 2014)
Royston, GB (2009 - 2015)

Company Filing History:

Cambridge Antibody Technology Limited

patents

where one patent can have more than one assignee

Years Active: 2007-2015

Loading Chart...

12 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8940874 - Neutralizing antibodies against GDF-8 and uses therefor (2015-01-27),

2. 8865166 - Antibodies to IL-17A and uses thereof (2014-10-21),

3. 8470993 - Nucleic acid encoding antibody to human IL-22 (2013-06-25),

4. 8420082 - Neutralizing antibodies against GDF-8 and uses therefor (2013-04-16),

5. 8187603 - Antibodies to human IL-22 (2012-05-29),

6. 8182817 - Antibodies to human IL-22 (2012-05-22),

7. 8088905 - Nucleic acids encoding antibodies against PD-1 (2012-01-03),

8. 7901684 - Antibodies against human IL-22 and uses therefor (2011-03-08),

9. 7655763 - Neutralizing antibodies against GDF-8 and uses therefor (2010-02-02),

10. 7521051 - Methods of upmodulating adaptive immune response using anti-PD-1 antibodies (2009-04-21),

11. 7488802 - Antibodies against PD-1 (2009-02-10),

12. 7261893 - Neutralizing antibodies against GDF-8 and uses therefor (2007-08-28),

Title: The Innovative Journey of Caroline S. Russell

Introduction

Caroline S. Russell, an accomplished inventor based in Hertfordshire, GB, has made significant strides in the field of biotechnology. Holding an impressive portfolio of 12 patents, she has contributed to groundbreaking research that addresses critical health issues.

Latest Patents

Among her latest inventions are two notable patents. The first, titled "Neutralizing antibodies against GDF-8 and uses therefor," showcases her development of novel antibodies targeting growth and differentiation factor-8 (GDF-8). This innovation has potential applications in diagnosing, preventing, or treating degenerative disorders of muscle or bone as well as disorders related to insulin metabolism. The second patent, "Antibodies to IL-17A and uses thereof," highlights her work with binding members, particularly antibody molecules for interleukin 17 (IL-17). These antibodies are aimed at treating conditions associated with interleukin 17, such as rheumatoid arthritis.

Career Highlights

Caroline's career includes pivotal roles at prominent companies in the biotechnology sector, such as Wyeth and Medimmune Limited. Her expertise and innovative spirit have led her to develop cutting-edge technologies that advance the field of medical research.

Collaborations

Throughout her career, Caroline has collaborated with other talented professionals, including Viia Valge-Archer and Geertruida Machteld Veldman. These partnerships have fostered an environment of creativity and innovation, further enhancing the impact of her work.

Conclusion

Caroline S. Russell stands out as a remarkable inventor whose contributions have paved the way for advancements in the treatment of various medical conditions. Her diligent work in developing therapeutic antibodies not only highlights her abilities as an inventor but also emphasizes the importance of collaboration in the pursuit of innovative solutions in healthcare.

Profile summary based on public USPTO records.